Clinical Study Data Request Registered Users, Please Login

Find by:

Study ID:
Medicine:
Phase:

A Phase 3, Randomized, Double-Blind, Parallel Group, Placebo and Active Controlled, Multicenter Study to Assess the Efficacy and Safety of Mirabegron (YM178) in Asian Patients with Symptoms of Overactive Bladder
mirabegron
178-CL-090
NCT01043666
Urinary Bladder, Overactive
Phase 3
 
October 2016

Powered by ideaPoint, Inc.